Skip to product information
1 of 1

GeneBio Systems

Recombinant Phospho-AKT1 (Thr450) Monoclonal Antibody

Recombinant Phospho-AKT1 (Thr450) Monoclonal Antibody

SKU:AN300087L

Regular price $256.00 USD
Regular price Sale price $256.00 USD
Sale Sold out
Shipping calculated at checkout.

Size::20μL

Storage:This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free. Avoid repeated freeze-thaw cycles.

Shipping:Ice bag

Exp date:12 months

Category ID_II:Primary Antibodies

Category ID_III:Recombinant Antibodies

Abbreviation:AKT1

Target Synonym:CWS;MGC;AKT serine/threonine kinase;AKT;CWS6;PKB;PKB-ALPHA;PRKBA;RAC;RAC-ALPHA;AKT1;AKT 1;AKT serine/threonine kinase 1;AKT1_HUMAN;MGC99656;Protein kinase B;Protein Kinase B Alpha;Proto-oncogene c-Akt;RAC Alpha;RAC-alpha serine/threonine-protein kinase;RAC-PK-alpha;AKT;AKT serine/threonine kinase 1;CWS6;PKB;PKB-ALPHA;PRKBA;RAC;RAC-ALPHA

Research Areas:Signal Transduction;Epigenetics and Nuclear Signaling;Cancer;Metabolism;Neuroscience

Conjugation:Unconjugated

Host:Rabbit

Species reactivity:Human

Application:WB

Isotype:IgG

Clonality:Rabbit Monoclonal

Clone NO.:11A3

UNIProt ID:P31749

Accession:

Background:The serine-threonine protein kinase encoded by the AKT1 gene is catalytically inactive in serum-starved primary and immortalized fibroblasts. AKT1 and the related AKT2 are activated by platelet-derived growth factor. The activation is rapid and specific, and it is abrogated by mutations in the pleckstrin homology domain of AKT1. It was shown that the activation occurs through phosphatidylinositol 3-kinase. In the developing nervous system AKT is a critical mediator of growth factor-induced neuronal survival. Survival factors can suppress apoptosis in a transcription-independent manner by activating the serine/threonine kinase AKT1, which then phosphorylates and inactivates components of the apoptotic machinery. Mutations in this gene have been associated with the Proteus syndrome. Multiple alternatively spliced transcript variants have been found for this gene.

Concentration:1 mg/mL

Immunogen:A synthetic phosphopeptide corresponding to residues around (Thr450) of the Human Phospho-AKT1

Buffer:10 mM sodium HEPES, 150 mM NaCl, 100 μg/mL protein protectant, 50% glycerol, pH 7.5

Purification method:Protein A

Dilution:WB 1:500-1:2000;

Calculated MW:55 kDa

ObservedMW:55 kDa

View full details